Kane Erin N 4

What Happened

• Erin N. Kane, a director of Chemours Co (CC), was granted 7,182 stock units on 2026-05-06. The reported acquisition price is $0.00 and the filing shows total reported value $0. This was an award/grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-06; Form 4 filed: 2026-05-08 (appears timely within the SEC 2-business-day window).
• Grant: 7,182 stock units at $0.00 (total $0 reported).
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — units convert one-for-one to Chemours common stock upon separation from Board service. F2 — includes deferred stock units and dividend equivalent units.
• No indication of a 10b5-1 plan, sale, or tax-withholding share forfeiture in this filing.

Context

• These appear to be director compensation units (deferred/restricted stock units and dividend equivalents) that convert to common shares upon leaving the board. Such grants are routine for non-employee directors and are generally administrative/compensation-related rather than a directional market signal.